Suppr超能文献

探讨针刺与假针刺治疗卵巢储备功能减退的疗效和安全性:一项多中心随机对照试验研究方案。

Exploring the efficacy and safety of acupuncture versus sham acupuncture for diminished ovarian reserve: study protocol for a multicentre randomised controlled trial.

机构信息

Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences (CACMS), Beijing, China.

Chengdu Xinan Gynecology Hospital, Chengdu, China.

出版信息

BMJ Open. 2024 Aug 19;14(8):e081098. doi: 10.1136/bmjopen-2023-081098.

Abstract

INTRODUCTION

The therapeutic needs of women with diminished ovarian reserve (DOR), coupled with the increasing application of acupuncture in improving ovarian function, have highlighted the need to verify the efficacy and safety of acupuncture for DOR. This study aims to provide high-quality evidence by evaluating both ovarian reserve and in vitro fertilisation (IVF) outcomes.

METHODS AND ANALYSIS

A large-scale, multicentre, randomised controlled trial will be carried out across seven hospitals in China. 400 women with DOR will be randomised in a 1:1 ratio to an acupuncture group or a sham acupuncture group. Acupuncture or sham acupuncture will consist of 36 sessions per participant over 12 weeks. The primary outcome will be the change in antral follicle count (AFC) at week 12 from baseline. Secondary outcomes are AFC at week 24, the serum levels of basal follicle-stimulating hormone and anti-Mullerian hormone at weeks 12 and 24, the scores of the Self-Rating Anxiety Scale at weeks 12 and 24, clinical pregnancy rate, and IVF embryo transfer related outcomes. Any adverse events during treatment will be documented.

ETHICS AND DISSEMINATION

The study protocol has been approved by all the participating institutions. Written informed consent will be obtained prior to participant enrolment. The results of this study will be published in peer-reviewed publications.

TRIAL REGISTRATION NUMBER

ChiCTR2200062295 PROTOCOL VERSION: V2.0-20220317.

摘要

简介

患有卵巢储备功能减退(DOR)的女性的治疗需求,加上针灸在改善卵巢功能方面的应用不断增加,这使得验证针灸对 DOR 的疗效和安全性变得尤为重要。本研究旨在通过评估卵巢储备和体外受精(IVF)结局,提供高质量的证据。

方法和分析

这是一项在中国 7 家医院开展的大规模、多中心、随机对照试验。将 400 名 DOR 患者按照 1:1 的比例随机分为针灸组或假针灸组。每个参与者接受 36 次针灸或假针灸治疗,共 12 周。主要结局是从基线到第 12 周时窦卵泡计数(AFC)的变化。次要结局是第 24 周时的 AFC、第 12 周和第 24 周时基础卵泡刺激素和抗苗勒管激素的血清水平、第 12 周和第 24 周时的自我评定焦虑量表评分、临床妊娠率以及 IVF 胚胎移植相关结局。记录治疗期间的任何不良事件。

伦理和传播

该研究方案已获得所有参与机构的批准。在参与者入组前将获得书面知情同意。本研究的结果将发表在同行评议的出版物上。

试验注册号

ChiCTR2200062295 方案版本:V2.0-20220317。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66dd/11337660/aa5cf48a1ffd/bmjopen-14-8-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验